Yiran Sherry’s waters broke while the family was stuck in traffic. With contractions increasing rapidly and traffic barely moving, the couple realized they were not going to make it in time.
Keating Sherry placed the vehicle on autopilot after setting the navigation system to the hospital, 20 minutes away in the western suburb of Paoli.
He said he laid one hand gently on the car’s steering wheel as he attended to his wife.
In 1971, scientists turned to genetics to control disease-spreading mosquitoes without DDT. Today, there are a variety of pesticide-free methods.
Join us on Patreon!
https://www.patreon.com/MichaelLustgartenPhD
Levine’s Biological age calculator is embedded as an Excel file in this link from my website:
In this short video, filmed at ASTRO 2021, Siemens Healthineers’ Gabriel Haras introduces the company’s portfolio of artificial intelligence (AI)-based products. Such technologies support the entire care pathway for cancer patients, from screening and diagnostics to treatment and follow-up, including innovations such as AI-based autocontouring and generation of synthetic CT from an MRI scan for radiotherapy planning.
Next, Varian’s Kevin O’Reilly comments on the combining of Varian and Siemens Healthineers into one united company. He notes that the integration of AI capabilities has increased Varian’s ability to innovate, and will help accelerate its intelligent cancer care strategy: accelerating the path to treatment, increasing global access to care, exploiting data-driven insight and improving personalization.
2021 saw massive growth in the demand for edge computing — driven by the pandemic, the need for more efficient business processes, as well as key advances in the Internet of Things, 5G and AI.
In a study published by IBM in May, for example, 94 percent of surveyed executives said their organizations will implement edge computing in the next five years.
From smart hospitals and cities to cashierless shops to self-driving cars, edge AI — the combination of edge computing and AI — is needed more than ever.
German drugmaker BioNTech is enrolling patients in a clinical trial to test its mRNA vaccine for colon cancer relapse.
Part 2
In this video Dr. Lustgarten goes into more detail on what he tracks and how he does the analysis of the results. He emphasizes the importance of running your own tests, to not only look at one biomarker but to then combine that marker with other biomarkers, looking for what is optimal for you.
Dr. Michael Lustgarten is a scientist at the Tufts University Human Nutrition Research Center on Aging in Boston, Massachusetts. His research currently focuses on the role of the gut microbiome and serum metabolome on muscle mass and function in older adults.
“How do we use these new innovative technologies to really mitigate disparities in diabetes outcomes?” asked Risa Wolf, a pediatric endocrinologist at Johns Hopkins Hospital.
Karlsruhe, germany and novato, CA, USA
The Forever Healthy Foundation and the Buck Institute for Research on Aging today announced a new partnership to advance early-stage discoveries at the Institute that show promise to reverse physiologic aging in humans. The focus will be on cutting-edge research aimed at the repair of age-related damage at the cellular and molecular level, a hallmark of the aging process. Forever Healthy will commit up to $1 million per year for five years to drive this innovation. The funding aims to advance early-stage research with high translational potential in order to speed up the transition from lab to product.
German entrepreneur and longevity pioneer Michael Greve founded his humanitarian Forever Healthy initiative with the mission of accelerating the development of therapies to impede the aging process and the diseases that accompany it. This mission is in perfect alignment with the Buck Institute, the first independent biomedical facility in the world focused solely on the biology of aging.
